Institutional Registry of Rare Diseases

Last updated: September 3, 2024
Sponsor: Hospital Italiano de Buenos Aires
Overall Status: Active - Recruiting

Phase

N/A

Condition

Amyloidosis

Sarcoidosis

Gastrointestinal Diseases And Disorders

Treatment

N/A

Clinical Study ID

NCT06573723
7014
12332
  • All Genders

Study Summary

The goal of this observational study is to create a single macro registry system with data collection on common clinical features, grouping the different rare diseases (RD).

Moreover, the specific goals are to generate an alert system for possible cases of RD with data from the electronic medical record, to describe the occurrence of RD in the evaluated population, to characterize the population, to describe patterns of diagnosis and treatment of RD present at the time, and to explore patient-reported outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Clinical and/or molecular diagnosis of any of the following rare diseases:Amyloidosis, Sarcoidosis, Phacomatosis, Pheochromocytoma, Paraganglioma, VonHippel-Lindau Disease, Immunoglobulin G4-Related Disease, Demyelinating Diseases,Inborn Errors of Metabolism, Eosinophilic Gastrointestinal Disorders, HypertrophicCardiomyopathy, Gaucher Disease, Congenital Adrenal Hyperplasia, HereditaryAngioedema, Pulmonary Hypertension, Wilson Disease, Vascular Anomalies,Mastocytosis, Multiple Endocrine Neoplasia, Inflammatory Bowel Diseases,Prader-Willi Syndrome, Hirschsprung Disease, or Cushing Syndrome.

  • Must be followed at Hospital Italiano de Buenos Aires.

Exclusion

Exclusion Criteria:

  • Refusal to participate in the study or in the informed consent process.

Study Design

Total Participants: 380
Study Start date:
July 01, 2024
Estimated Completion Date:
December 31, 2034

Study Description

Rare Diseases (RD) pose a health challenge due to their complexity and low prevalence, generating a burden in terms of morbidity and mortality and costs.

The fragmentation of data on these diseases makes it difficult to understand them comprehensively. Therefore, the creation of a macro institutional registry that brings together information on RD would facilitate research in this field.

The registries are organized systems of systematic data collection of a large number of patients quickly and efficiently on a particular disease at a given time.

The main difficulty of the registries is the guarantee of the quality of their data.

The main objectives of the registry are:

Understand risk factors and prognosis. Evaluate the diagnostic and therapeutic comparison with current standards. Advance knowledge of the disease to optimize the assessment, treatment and monitoring of patients.

Analyze the effectiveness of new therapies. Studying differences between populations. Quickly estimate the morbidity, mortality and resource utilization associated with a disease entity.

Examine the course of a disease Formulate novel hypotheses for further prospective studies.

Connect with a study center

  • Hospital Italiano de Buenos Aires

    Buenos Aires, C1199
    Argentina

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.